Summary We have studied the role of the oxygen-dependent pyrimidine metabolism in the regulation of cell cycle progression under moderate hypoxia in human cell lines containing functional (T-47D) or non-functional (NHIK 3025, SAOS-2) retinoblastoma gene product (pRB). Under aerobic conditions, pRB exerts its growth-regulatory effects during early G, phase of the cell cycle, when all pRB present has been assumed to be in the underphosphorylated form and bound in the nucleus. We demonstrate that pRB is dephosphorylated and re-bound in the nucleus in approximately 90% of T-47D cells located in S and G2 phases under moderately hypoxic conditions. Under these conditions, no T-47D cells entered S-phase, and no progression through S-phase was observed. Progression of cells through G2 and mitosis seems independent of their functional pRB status. The p21 WAF1/CIP1 protein level was significantly reduced by moderate hypoxia in p53-deficient T-47D cells, whereas p1 6INK4a was not expressed in these cells, suggesting that the hypoxia-induced cell cycle arrest is independent of these cyclindependent kinase inhibitors. The addition of pyrimidine deoxynucleosides did not release T-47D cells, containing mainly underphosphorylated pRB, from the cell cycle arrest induced by moderate hypoxia. However, NHIK 3025 cells, in which pRB is abrogated by expression of the HPV18 E7 oncoprotein, and SAOS-2 cells, which lack pRB expression, continued cell cycle progression under moderate hypoxia provided that excess pyrimidine deoxynucleosides were present. NHIK 3025 cells express high levels of p16INK4a under both aerobic and moderately hypoxic conditions, suggesting that the inhibitory function of p1 6INK4a would not be manifested in such pRB-deficient cells. Thus, pRB, a key member of the cell cycle checkpoint network, seems to play a major role by inducing growth arrest under moderate hypoxia, and it gradually overrides hypoxia-induced suppression of pyrimidine metabolism in the regulation of progression through S-phase under such conditions.
Limitations in oxygen supply because of defective or insufficient tissue vasculature results in hypoxia. It is generally accepted that oxygen deficiency is a common occurrence in many human solid tumours, and that hypoxic cells may contribute to the observed resistance of solid tumours to radiation and chemotherapeutic agents (Hockel et al, 1993; Teicher, 1994) .
To maintain cellular homeostasis under hypoxic stress, cells respond by inducing cell cycle arrest (Koch et al, 1973; Loffler et al, 1978; Amellem and Pettersen, 199 la), apoptosis (Graeber et al, 1996;  Amellem et al, 1997), reducing energy-demanding protein synthesis, but increasing protein degradation (Pettersen et al, 1986;  Amellem and Pettersen, 1991b) . Furthermore, they induce several stress-related gene products (Sciandra et al, 1984; Anderson and Farkas, 1988; Heacock and Sutherland, 1990; Price and Calderwood, 1992; Shi et al, 1993) , all of which may serve a timelimited role in protecting cells from the lethal effects of hypoxia.
Cells in the G, phase have developed such protective properties (Merz and Schneider, 1983; Spiro et al, 1984; Amellem and Pettersen, 1991a) . Recent studies have indicated that the tumour suppressor proteins, p53 and pRB, play important roles in the maintenance of cellular homeostasis under and after hypoxic stress (Graeber et al, 1996; Amellem et al, 1996 Amellem et al, , 1997 .
The product of the retinoblastoma gene, pRB, is a nuclear phosphoprotein with tumour-suppressing activities that is normally thought to function in transcriptional control of the cell cycle (reviewed by Weinberg, 1995) . The growth suppressive activity of pRB is controlled at the level of phosphorylation (Chen et al, 1989; DeCaprio et al, 1989; Mihara et al, 1989) , whereas the different pRB-kinase complexes are controlled by two families of cyclindependent kinase (cdk) inhibitory proteins. The p16 family inhibits the formation of cyclin D-dependent kinase complexes, whereas p2lWAF /CIPI and p27KIP1 are more broadly acting kinase inhibitors (reviewed by Sherr and Roberts, 1995) . The amount of pRB protein increases in proportion with cell age throughout the cell cycle (Stokke et al, 1993) . The underphosphorylated form of pRB, which is found in early G,, is functionally active. pRB is phosphorylated 6-7 h before the G,/S-border and then throughout S and G2 phases and thereby loses its growth suppressive effect (reviewed by Sherr, 1994) . Dephosphorylation of pRB starts in late stages of mitosis (Ludlow et al, 1993a) . pRB may exert its growthsuppressive properties by interaction with transcription factors of the E2F, family (Bagchi et al, 1991; Chellappan et al, 1991) . It is believed that phosphorylation of pRB in GI disrupts complex formation with E2F, allowing expression of E2F-regulated genes required for progression into S-phase and enzymes essential for DNA synthesis (Lam and La Thangue, 1994) . In addition, pRB has recently been shown to be a more global repressor of genes by negatively regulating the activity of all three classes of nuclear RNA polymerases (Cavanaugh et al, 1995; White et al, 1996) .
Several viral oncoproteins, including the HPV E7 oncoprotein (Dyson et al, 1989) , bind only to the underphosphorylated form of pRB. By doing so, they presumably promote cells to proceed through the cell cycle by blocking pRB's normal functions. Indeed, the HPV E7 protein as well as the simian virus 40 large tumour antigen can dissociate the E2F-pRB complex, and this protein complex is shown to be absent in various human cervical carcinoma cell lines that express the HPV E7 oncoprotein (Chellappan et al, 1992) .
Regulation of DNA precursor metabolism plays a central role in connection with the suppression of cell growth under hypoxic conditions. It appears that reduced progression through S-phase is halted or inhibited under moderate hypoxia (greater than approximately 100 p.p.m. oxygen) due to reduced de novo synthesis of pyrimidine deoxynucleotides (Loffler, 1992; Amellem et al, 1994) . Suppression of the enzymatic activity of two enzymes, which both depend on the presence of molecular oxygen, dihydroorotate dehydrogenase and ribonucleotide reductase, is presumably responsible for the reduced pyrimidine deoxynucleotide pools observed during hypoxia (Loffler et al, 1983) . In some cells, addition of pyrimidine deoxynucleosides (such as deoxycytidine) under moderate hypoxia is used by the salvage pathway to restore the dCTP/dTTP pools and thus cell cycle progression (Amellem et al, 1994) .
In the present paper, we investigate the role of the cell cycle checkpoint network (i.e. pRB) vs the biosynthetic machinery (i.e. pyrimidine metabolism), which are both potentially important components in the regulation of cell cycle progression under hypoxic conditions. We demonstrate that addition of pyrimidine deoxynucleosides to cells exposed to moderate hypoxia do not overcome the inhibition of DNA synthesis in cells with functional pRB, in contrast to cells in which pRB is non-functional. This indicates that inhibition of cell cycle progression under hypoxic conditions is primarily regulated through the cell cycle checkpoint network, i.e. pRB, and secondly at the biosynthetic level through pyrimidine metabolism.
MATERIALS AND METHODS Cell cultures
The human breast cancer cell line T-47D (Keydar et al, 1979) was grown as a monolayer culture in RPMI-1640 medium (Gibco), supplemented with 10% fetal calf serum (Gibco), 2 mM L-glutamine (Gibco), 200 units l-1 insulin, and 1% penicillin/streptomycin (Gibco), at 37°C in air containing 5% carbon dioxide. The doubling time for an exponentially growing population of T-47D cells was 37.2 ± 2 h (Stokke et al, 1993) . The human osteosarcoma cell line SAOS-2 was grown as monolayer culture in RPMI-1640 medium (Gibco), supplemented with 10% fetal calf serum (Gibco), 2 mM L-glutamine (Gibco), and 1% penicillin/streptomycin (Gibco), at 37°C in air containing 5% carbon dioxide. The human cervical carcinoma cell line NHIK 3025 Oftebro and Nordbye, 1969) was grown as a monolayer culture in E2a medium (Puck et al, 1957) containing 20% human serum (prepared in the laboratory), 10% horse serum (Gibco), 2 mM L-glutamine (Gibco), and 1% penicillin/streptomycin (Gibco), at 37°C in air supplied with 5% carbon dioxide. NHIK 3025 cells contain integrated HPV1 8 and express the HPV1 8 E7 oncoprotein (Figure 4 ). The median cell cycle duration for NHIK 3025 cells was 16.5 h (Amellem et al, 1994) . All cell lines were kept in exponential growth by reculturing three times a week.
Hypoxic cell cultures
The cells were seeded in 70-mm glass dishes (Anumbra, Czech Republic) 1 day before the experiment and incubated in a carbon dioxide incubator. At the appropriate time, the glass dishes were brought from the carbon dioxide incubator into a walk-in incubator room at 37°C. The medium content in each dish was reduced from 10 to 3.5 ml and placed without lids in a stainless steel chamber. Deoxygenation took place by continuous flushing of the chamber with a gas mixture (Hydro Gas, Norway) of highly purified 97% nitrogen, 3% carbon dioxide, and 100 or 1300 p.p.m. oxygen at 37°C, as described previously (L0vhaug et al, 1977) . The hypoxic atmosphere in the chamber was established about 12 min after the start of flushing. Untreated control populations were kept in the carbon dioxide incubator during the experiment.
Extraction, fixation and staining for measurement of nuclear-bound pRB and DNA content All steps were carried out at 0°C. Harvested cells were washed once in phosphate-buffered saline (PBS). Detergent-extracted fixed cells were prepared by resuspending cells in 1.5 ml of lowsalt detergent buffer [10 mm sodium chloride, 5 mm magnesium chloride, 0.1 mm phenylmethylsulphonyl fluoride, 0.1% Nonidet P-40, 10 mm phosphate buffer (pH 7.4)]. After 15 min, the extracted cells, which will be termed nuclei, were added to 0.5 ml of 4% paraformaldehyde under vortexing. Nuclei were fixed for 1 h, and then washed twice in washing buffer [10 mm Tris, 0.15 mm sodium chloride, 2 mm magnesium chloride and 0.1% Triton X-100 (pH 7.4)]. pRB was detected using the PMG3-245 monoclonal antibody (Pharmingen), which recognized both the underand hyperphosphorylated forms of the protein (Mittnacht and Weinberg, 1991; Dowdy et al, 1993; Stokke et al, 1993) . pRB staining was accomplished by a three-layer procedure. Nuclei were resuspended in 25 gl of 5% non-fat dry milk dissolved in washing buffer. Ten minutes later the anti-pRB monoclonal antibody was added to a final concentration of 2 gg ml-' in a total of 50 gl. The control samples received PBS and no primary antibody (data not shown). After a 30-min incubation, the nuclei were washed twice and incubated for 30 min in 100 pl of biotinylated horse anti-mouse IgG1 (HAM) (Vector) C) Figure 3 The fraction of cells in G1, S and G2 exposed to moderate hypoxia and the corresponding fraction of pRB+ nuclei in the various cell cycle phases. T-47D cells were exposed to aerobic or moderately hypoxic conditions (1300 p.p.m. oxygen) for 20 h. Some cell populations were supplemented with medium containing 0.1 mm deoxycytidine (dC) during moderate hypoxia. The data were generated from the flow cytometric histograms shown in Figure (Laemmli, 1970) , containing 0.1 mm phenylmethylsulphonyl fluoride, 25 jg ml-aprotinin, 24 giM leupeptin and 100 nM okadaic acid on ice. The whole-cell extracts were heated in boiling water for 5 min. Equal amounts of whole-cell protein extracts were loaded in each lane and separated by electrophoresis in 8% discontinuous SDS-polyacrylamide gels (Laemmli, 1970) (Hagmar et al, 1992) . Both these primers were located within the E7 gene. Another lower primer, p3E4 (GGA ATA CGG TGA GGG GGT GTG), from position 3483 to 3503 within the E4 gene was used with the same upper primer (plE7) in separate reactions (see Figure 4A ). The reverse transcriptase was omitted in the control reactions to confirm the absence of DNA contamination in the reaction tubes. The PCR products were analysed on 3% NuSieve GTG agarose gels (FCM) and stained with ethidium bromide.
RESULTS
Addition of pyrimidine deoxynucleosides do not overcome the inhibition of DNA synthesis induced by moderate hypoxia in cells expressing wild-type pRB
In T-47D cells grown under aerobic conditions, the pRB retained in the nuclei was predominantly in its phosphorylated form ( Figure 1 , lane 1), which is confirmed by the high fraction of pRBnuclei measured by flow cytometry ( Figure 2D ). (Figure 1, lane 3) .
To relate the effect variations of nuclear binding of pRB (pRB+) during moderate hypoxia to the cell cycle stage, the fraction of pRB+ nuclei were generated from flow cytometric list mode data for nuclei derived from cells in G I S and G2 phases of the cell cycle. For aerobic (i.e. control) T-47D cells, pRB+ nuclei were found in the G, phase only ( Figure 2D) . A dramatic change in the fraction of pRB+ nuclei was observed after 20 h exposure to moderate hypoxia (1300 p.p.m. oxygen) (Figure 2 h ). The most pronounced increase in the fraction of pRB+ nuclei (dephosphorylation of pRB) occurred for T-47D cells in S and G2, whereas only a modest increase was observed in the fraction of pRB+ nuclei in G, (Figure 2 h ).
British Journal of Cancer (1998) 77(6) (Boshart et al, 1984) . Agarose gel electrophoresis of DNA from the RT-PCR amplification of the HPV1 8 probes was visualized by staining with ethidium bromide
In a previous study, we showed that addition of deoxycytidine during moderate hypoxia in NHIK 3025 cells reversed the cell cycle-inhibitory effect of hypoxia (Amellem et al, 1994) . In the present study, we therefore added 0.1 mm deoxycytidine to see if this treatment could reverse the hypoxia-induced arrest that was related to the rebinding (dephosphorylation) of pRB to nuclear structures in cells in S-phase. The data show, however, that neither the increase in the fraction of pRB+ nuclei nor the cell cycle progression itself are affected by the addition of deoxycytidine under moderate hypoxia ( Figure 2L ). These data support our observation made by Western blotting (Figure 1, lane 3) , indicating that pRB becomes dephosphorylated under moderate hypoxia both in the absence and in the presence of pyrimidine deoxynucleosides.
To visualize the magnitude of the changes in the fraction of pRB+ nuclei in various cell cycle phases of the T-47D cells as presented in Figure 2D , H, and L, the fraction of pRB+ nuclei was analysed for each cell cycle phase, and the results are shown in Figure 3 . The fraction of pRB+ nuclei with S and G2 DNA content increased from 0.05 to > 0.90 during 20 h exposure to moderate hypoxia ( Figure 3B and 3C ). In comparison, the increase in the fraction of pRB+ nuclei with G, DNA content taking place during the same treatment was less pronounced (from 0.37 to 0.76, Figure 3A ).
DNA-replicating cells incorporate BrdUrd into their DNA (BrdUrd+), and are easily distinguishable from non-BrdUrd-labelled cells (BrdUrd-) (Figure 2A) . In a pulse-chase experiment, exponentially growing T-47D cells were labelled with BrdUrd before the hypoxic treatment. The fraction of BrdUrd+ with S-phase DNA content remained unchanged if one compares the situation immediately after the pulse and before hypoxia (i.e. aerobic conditions, Figure 2A and 2C) and after 20 h exposure to 1300 p.p.m. oxygen ( Figure 21 and K) , which means that no T-47D cells have left Sphase under 20 h of moderately hypoxic conditions. In contrast, the fraction of BrdUrd+ with S-phase DNA content reached GI of the subsequent cell cycle if one compares the situation immediately after the pulse (Figure 2A and C) with the situation after 20 h exposure to aerobic conditions ( Figure 2E and G). The presence of deoxycytidine under moderate hypoxia had no effect on the fraction of BrdUrd+ cells in S-phase ( Figure 2M and 0) , indicating that the addition of pyrimidine deoxynucleosides did not abolish the hypoxia-induced S-phase arrest. It was also evident from the fraction of BrdUrd-cells present, that, in contrast to the situation seen under aerobic conditions ( Figure 2E and F) , no T-47D cells enter Sphase under these hypoxic conditions ( Figure 2J and N) . Only in the G2 compartment was a small decrease observed in the fraction of BrdUrd-cells after moderate hypoxia (compare Figure 2A with (Stokke et al, 1993) and flow cytometry (data not shown). RT-PCR was used to identify the expression of the HPV18 E7 gene in NHIK 3025 cells ( Figure 4B , lanes 2 and 3). One upper primer in combination with either one of two lower primers from different parts of the HPV18 genome yield two products, confirming the expression of the E7 and the E7AE4 type transcripts (173 and 430 bp respectively). The RT-PCR was performed using one negative control (MCF-7 cells) (Figure 4b , lane 8), one positive HPV18 control from HeLa S3 cells ( Figure  4b , lanes 5 and 6), and two reaction controls in which reverse transcriptase was excluded to ensure the absence of DNA contamination in the reaction tubes ( Figure 4B, lanes 4 and 7) . The HPV1 8 E7 oncoprotein has the ability to bind and thus inactivate pRB (Tommasino and Crawford, 1995) . To induce a similar degree of cell cycle inhibition in NHIK 3025 cells as induced by 1300 p.p.m. oxygen in T-47D cells, we had to reduce the concentration to only 100 p.p.m. oxygen.
In a pulse-chase experiment, exponentially growing NHIK 3025 cells were labelled with BrdUrd before the hypoxic treatment. More than half the population of cells, initially labelled with BrdUrd (BrdUrd+) (Figure SC Figure 5H with K).
Addition of pyrimidine deoxynucleosides overcome the inhibition of DNA synthesis induced by moderate hypoxia in cells which lack pRB expression
To further determine whether the hypoxia-induced cell cycle arrest in pRB-deficient cells is due to lack of pyrimidine deoxynucleosides, we exposed SAOS-2 cells to 1300 p.p.m. oxygen for 18 h in the absence or presence of 0.1 mM deoxycytidine ( Figure 6 ). SAOS-2 cells lack functional pRB (Ewen et al, 1993) . Exponentially growing SAOS-2 cells were pulse-labelled with BrdUrd before the hypoxic treatment. We found that more than half the population of cells, initially labelled with BrdUrd (BrdUrd+) ( Figure 6A ), remained in S-phase after 20 h exposure to 1300 p.p.m. oxygen ( Figure 6C ). However, most of these BrdUrd+ cells arrested in S-phase under moderate hypoxia were able to complete DNA synthesis in the presence of 0.1 mm deoxycytidine (compare Figure 6C with D, Figure 7D ). Even in the presence of deoxycytidine the rate of cell cycle progression was still reduced under moderately hypoxic compared with under aerobic conditions (compare Figure 6B with D) . Some of the cells initially in GI (BrdUrd-) entered S-phase under these hypoxic conditions (compare Figure 6A with C). These results support the experiment presented in Figure 5 , suggesting that in the absence of functional pRB inhibition of de novo synthesis of pyrimidine deoxynucleotides is the main mechanism responsible for the hypoxiainduced arrest in S-phase. Analysis of the DNA distribution in the BrdUrd-and the BrdUrd+ fraction in both T-47D (Figure 2) , NHIK 3025 cells ( Figure 5 ) and SAOS-2 cells (Figure 6 ) are presented in Figure 7 .
British Journal of Cancer (1998) 77(6) (Figure 8 , lanes 3 and 4 respectively). In contrast, pRB-deficient NHIK 3025 cells expressed high levels of pl6INK4a under both aerobic conditions and after 20 h exposure to moderately hypoxic conditions (Figure 8 , lanes 1 and 2 respectively). As T-47D cells express mutated p53 (Bartek et al, 1990) , and the wild-type p53 functions is abrogated by the presence of HPV E6 in NHIK 3025 cells, the induction of p2lwAFlcIPIl must occur independently of p53. Both NHIK 3025 and T-47D cells express low levels of p2lWAFI/CIP1 under aerobic conditions (Figure 8, lanes 1 and 3  respectively) . However, p2lWAF1/cIP1 decreased below the detection level in both these cell types after exposure to moderately hypoxic conditions for 20 h (Figure 8 , lanes 2 and 4 respectively).
DISCUSSION Cell cycle regulation during moderate hypoxia in cells with functional or non-functional pRB
The results presented here demonstrate that pRB is dephosphorylated ( Figure 1 ) and re-bound (here termed pRB+) ( Figure 2H and L) in the nucleus in T-47D cells under moderate hypoxia (1300 p.p.m. oxygen). This marked change in the state of pRB phosphorylation towards a more under-phosphorylated form under moderately hypoxic conditions is most pronounced in the nucleus of cells in the S and G2 phases of the cell cycle. In more than 90% of these cells, pRB is dephosphorylated and re-bound in the nucleus during a 20 h treatment with moderate hypoxia, which is (Figure 2 ). The slow dephosphorylation of pRB, as observed under extremely hypoxic conditions (Amellem et al, 1996) , indicates that the immediate arrest is due to mechanisms other than pRB. The slow dephosphorylation of pRB, however, can explain why cells that are in G2 at the onset of hypoxia complete the cell cycle and enter GI of the next cell cycle during hypoxia (Figure 2) . Hypoxic stress, which becomes increasingly toxic with time, particularly to cells in Sphase (Merz and Schneider, 1983; Spiro et al, 1984; Amellem and Pettersen, 1991a) , may activate pRB to prevent harmful effects that could follow from continued DNA replication during hypoxia. Several lines of evidence have linked the under-phosphorylated form of pRB to its role as an inhibitor of cell cycle progression through G, (reviewed by Weinberg, 1995) . It is, therefore, tempting to suggest that dephosphorylation of pRB under moderate hypoxia is also responsible for the hypoxia-induced cell cycle arrest in S-phase. The hypoxia-induced dephosphorylation of pRB could be due to either a prevention of a kinase or an activation of a phosphatase or both. The growth-suppressing activity of pRB is down-regulated by various cdks (i.e. cdk4/6-cyclin D, cdk2-cyclin E and cdk2-cyclin A) whose kinase activity is negatively regulated by cdk inhibitors of the p16 and p21 families. As p21WAF1/CIPI, and the related p27'P1, can associate with multiple cyclin-cdk complexes, associated with G, and S-phases (reviewed by Sherr and Roberts, 1995) , it is most likely that they can exert controls at multiple points in the cell cycle. A possible explanation to the dephosphorylation of pRB during hypoxia could, therefore, be that it is mediated by p53-dependent activation of p211l/C 1. However, the p53 gene is mutated in T-47D cells (Nigro et al, 1989 ), and the p53 protein level does not change in response to neither hypoxia (Amellem et al, 1997) nor irradiation (data not shown), indicating that p53 is not involved in the possible inhibition of pRB kinases during hypoxia. This supports the view that dephosphorylation of pRB is due to activation of a pRB phosphatase in the absence of constitutive pRB kinase activity. This view is further supported by our previous results, showing that dephosphorylation of pRB under extremely hypoxic conditions is independent of the p53 gene status (Amellem et al, 1996) . It has been suggested that pRB-mediated G, arrest, independent of p53, could be achieved through activation of a pRB phosphatase (Dou et al, 1995; An and Dou, 1996) . On the other hand, p2lWAFl/CIPl can also be activated by p53-independent mechanisms (Macleod et al, 1995; Russo et al, 1995) . Our results show that both T-47D and NHIK 3025 cells express low levels of p2lwAFIl/cPl under aerobic conditions. T-47D cells have previously been shown to express barely detectable levels of p21WAF1/cIPl mRNA (Sheikh et al, 1994) . However, p21wAFI/CIP1 was not detectable by Western blot analysis under moderately hypoxic conditions in both these cell types. In addition, pl6INK4a was not detectable in T-47D cells, whether the cells were cultured under aerobic or moderately hypoxic conditions. Furthermore, two other members of the p16 family, p15INK4b and p18INK4c, are found to be mutated in T-47D cells (Zariwala et al, 1996) . Taken together, these data suggest that neither members of the p16 family nor p21WAF1/CIP1 are involved in the hypoxia-induced cell cycle arrest in p53-deficient T-47D cells. The observed dephosphorylation of pRB under moderate hypoxia did not depend on the activation of cdk inhibitors, supporting the suggestion above that dephosphorylation is due to activation of a pRB phosphatase. Furthermore, hypoxia has been shown to induce p21WAF1/CIP1, but only in a wild-type p53-dependent manner (Graeber et al, 1994) . In general, the p53-dependent expression of p21 WAFI/CIPi has mainly been associated with the induction of cell cycle arrest (reviewed by Sherr and Roberts, 1995) . However, recent studies have suggested that the role of p53 under hypoxic conditions is not associated with cell cycle arrest (Graeber et al, 1994) , but merely with the induction of apoptosis (Graeber et al, 1996; Amellem et al, 1997) . Thus, the function of p21WAFl/cIPl under hypoxic conditions remains unknown.
In contrast to T-47D cells, the human cervical carcinoma NHIK 3025 cells express the HPV18 E7 oncoprotein (Figure 4 ), known to bind pRB and thereby inhibit its normal function. We were unable to detect any pRB in NHIK 3025 cells as measured by flow cytometry (data not shown) and Western blotting (Stokke et al, 1993) . However, this pRB-deficient cell line express high levels of pl6INK4a under both aerobic and hypoxic conditions. A high level of p16lNK4a has been shown previously in other cervical carcinoma cell lines (Parry et al, 1995) . Overexpression of pl6INK4a has been reported to prevent proliferation in pRB-functional cells, but is ineffective in pRB-deficient cells (Guan et al, 1994 (Amellem et al, 1994) , are active in these cells, even under moderate hypoxia, and prevent them from leaving GI. This is in contrast to the situation in NHIK 3025 cells where the oxygen concentration has to be reduced below 20 p.p.m. to completely inhibit entry into S-phase (Pettersen and Lindmo, 1983 (Figure 5 ). Although the normal dNTP pools are in general sufficient for only a few minutes of DNA synthesis (Reichard, 1988) , some NHIK 3025 cells are still able to progress out of S-phase and even further into the next cell cycle ( Figure 5 ). This indicates that the oxygendependent DNA precursor metabolism continues to be active for a few hours even at oxygen concentrations as low as 100 p.p.m. before the NHIK 3025 cells become arrested.
The E7 oncoprotein has been shown to disrupt the interaction between the transcription factor E2F and pRB, and this protein complex is absent in various cervical carcinoma cell lines that express E7 (Chellappan et al, 1992) . This protein complex is believed to result in the growth suppressive function that pRB exerts in the early parts of G, (Bagchi et al, 1991; Helin et al, 1993; Lees et al, 1993) . E7 binds only to the under-phosphorylated form of pRB (Dyson et al, 1989) , which is its functional form. By doing so, E7 presumably promotes cells to proceed through the cell British Journal of Cancer (1998) cycle. Indeed, expression of the E7 oncoprotein allows cell cycle progression, both under hypoxic conditions ( Figure 5 ) and after DNA damage induced by irradiation (Hickman et al, 1994; Slebos et al, 1994) .
The role of pyrimidine metabolism in the regulation of cell proliferation under moderate hypoxia in cells with functional or non-functional pRB Addition of deoxynucleosides to T-47D cells during exposure to moderate hypoxia did not counteract the hypoxia-induced cell cycle arrest in these cells (Figures 1 and 2) . Similar lack of response has also been found in other cell types with normal pRB status, such as MCF-7 and Reh cells (data not shown). We can rule out the possible explanation that hypoxia might have induced some perturbation of the salvage pathway, as the thymidine analogue BrdUrd was readily incorporated into DNA. Instead, it is more likely that cell cycle inhibition in T-47D cells under protracted moderate hypoxia is due to activation of pRB. This is highly supported by our observation that hypoxia-induced cell cycle arrest of NHIK 3025 cells ( Figure 5 ) and SAOS-2 cells (Figure 6 ), both lacking functional pRB, was abolished by addition of pyrimidine deoxynucleosides (i.e. dC). It is also in accordance with this explanation that the addition of exogenously added deoxycytidine did not affect the phosphorylation state of pRB in T-47D cells under moderate hypoxia (Figure 1) , i.e. pRB also remained dephosphorylated in the presence of excess amounts of deoxynucleosides. pRB, thus, seems to over-rule the stimulatory effect of addition of deoxynucleosides, and, therefore, may be the main regulator of cell proliferation under moderate hypoxia. One important aspect, here, is the slow kinetics regarding the hypoxiainduced dephosphorylation of pRB (Amellem et al, 1996) . This implies that the immediate arrest observed under moderate hypoxia in T-47D cells is mediated by some mechanisms other than through the pRB pathway. One possible explanation is that the oxygen-dependent catalytic activity of dihydroorotate dehydrogenase and/or ribonucleotide reductase in T-47D cells needs higher concentrations of oxygen than the concentrations needed in NHIK 3025 or SAOS-2 cells in order to be enzymaticaly functional. However, this remains to be elucidated.
The suppressive effects of pRB is supposed to be mediated by the underphosphorylated form of the protein (Buchkovich et al, 1989; DeCaprio et al, 1989; Mihara et al, 1989) by sequestering the transcription factor E2FI-3 (Bagchi et al, 1991; Chellappan et al, 1991) . If, therefore, moderate hypoxia promotes rebinding of pRB to E2F-1, we can have a simple explanation of how pRB inhibit progression through S-phase during such hypoxia. Recently, it has been demonstrated that genes encoding S-phasespecific proteins are induced by E2F-1 [including both subunits of ribonucleotide reductase (RI and R2), DNA polymerase o, thymidylate synthase, proliferating cell nuclear antigen] (DeGregori et al, 1995) . In addition, E2F-1 has been shown to be a prerequisite for the expression of genes implicated in growth control (including cdc2, cyclin A, cyclin E, c-myc, B-myb, and the E2F-1 gene itself) that have E2F-binding sites in their promoters (reviewed by . For example, cyclin A, which is involved in the control of cell cycle progression through S-phase, and at the entry into mitosis (Girard et al, 1991; Pagano et al, 1992) , is reduced in hypoxia-arrested cells in S-phase (Ludlow et al, 1993b) . Another possibility that might explain the involvement of pRB in hypoxia-induced growth arrest is the recent discovery that pRB can inhibit cell proliferation through a more global regulation of genes by repressing the transcription of all three classes of nuclear RNA polymerases (Cavanaugh et al, 1995; White et al, 1996) . Thus, from the present as well as previous results, it seems that the hypoxia-induced cell cycle arrest is due to both a direct inhibition of DNA synthesis (Loffler, 1992; Amellem et al, 1994) and by activation of pRB (Ludlow et al, 1993b ; this study), a key member of the cell cycle checkpoint network, with E2F-1 as a possible link between them.
Addition of pyrimidine deoxynucleosides to NHIK 3025 and SAOS-2 cells partly reversed the S-phase arrest induced by moderate hypoxia. However, normal rate of cell cycle progression was not established, indicating that additional mechanisms regulate the rate of cell proliferation under such conditions. Similar effects have been observed in Ehrlich ascites cells (Loffler, 1992) . Whether these cells contain wild-type pRB has, to our knowledge, not been investigated. From our own data on NHIK 3025 and SAOS-2 cells, we conclude as follows: in the absence of pRB checkpoint control, the oxygen-dependent de novo synthesis of pyrimidine deoxynucleotides seems to be the major limiting step in the control of cell cycle progression through S-phase under moderately hypoxic conditions. It seems, from the present data, that the pRB status survey the physiological growth conditions of the cell, and that it may, thus, function as a stress indicator in the cell. This is, however, a slowlyacting regulation and even in cells with functional pRB the immediate arrest in S-phase after the onset of moderate hypoxia is believed to be a consequence of blocking de novo synthesis of pyrimidine deoxynucleotides due to inhibition of the two oxygendependent enzymes, dihydroorotate dehydrogenase and ribonucleotide reductase (Probst et al, 1989; Loffler, 1992; Amellem et al, 1994; Brischwein et al, 1997 ). An additional explanation proposed by Probst et al (1988) suggests that hypoxia inhibits the initiation of new replicones, whereas DNA chain elongation and termination proceed during hypoxia. They further demonstrated that replicon initiation depends on one or several short-lived proteins that are also formed under hypoxic conditions, suggesting that hypoxic cells in S-phase are arrested in a state fully prepared for entering DNA replication (Riedinger et al, 1992) .
The dephosphorylated form of pRB seem to take over as the main negative regulator about 4 h after the hypoxia-induced cell cycle arrest (Amellem et al, 1996) . Thus, the molecular downregulation of DNA replication under moderate hypoxia is gradually overridden by a member of the cell cycle checkpoint network, pRB, which seems to serve as the main regulator of progression through S-phase under moderately hypoxic conditions.
